220 related articles for article (PubMed ID: 25936516)
1. Chimeric peptides as modulators of CK2-dependent signaling: Mechanism of action and off-target effects.
Zanin S; Sandre M; Cozza G; Ottaviani D; Marin O; Pinna LA; Ruzzene M
Biochim Biophys Acta; 2015 Oct; 1854(10 Pt B):1694-707. PubMed ID: 25936516
[TBL] [Abstract][Full Text] [Related]
2. Cell cycle regulatory protein p27KIP1 is a substrate and interacts with the protein kinase CK2.
Tapia JC; Bolanos-Garcia VM; Sayed M; Allende CC; Allende JE
J Cell Biochem; 2004 Apr; 91(5):865-79. PubMed ID: 15034923
[TBL] [Abstract][Full Text] [Related]
3. CIGB-300 anticancer peptide regulates the protein kinase CK2-dependent phosphoproteome.
Perera Y; Ramos Y; Padrón G; Caballero E; Guirola O; Caligiuri LG; Lorenzo N; Gottardo F; Farina HG; Filhol O; Cochet C; Perea SE
Mol Cell Biochem; 2020 Jul; 470(1-2):63-75. PubMed ID: 32405972
[TBL] [Abstract][Full Text] [Related]
4. New protein kinase CK2 inhibitors: jumping out of the catalytic box.
Prudent R; Cochet C
Chem Biol; 2009 Feb; 16(2):112-20. PubMed ID: 19246001
[TBL] [Abstract][Full Text] [Related]
5. Toward selective CK2alpha and CK2alpha' inhibitors: Development of a novel whole-cell kinase assay by Autodisplay of catalytic CK2alpha'.
Bollacke A; Nienberg C; Borgne ML; Jose J
J Pharm Biomed Anal; 2016 Mar; 121():253-260. PubMed ID: 26786382
[TBL] [Abstract][Full Text] [Related]
6. Yeast holoenzyme of protein kinase CK2 requires both beta and beta' regulatory subunits for its activity.
Kubiński K; Domańska K; Sajnaga E; Mazur E; Zieliński R; Szyszka R
Mol Cell Biochem; 2007 Jan; 295(1-2):229-36. PubMed ID: 16933028
[TBL] [Abstract][Full Text] [Related]
7. Design of CK2β-Mimicking Peptides as Tools To Study the CK2α/CK2β Interaction in Cancer Cells.
Lindenblatt D; Horn M; Götz C; Niefind K; Neundorf I; Pietsch M
ChemMedChem; 2019 Apr; 14(8):833-841. PubMed ID: 30786177
[TBL] [Abstract][Full Text] [Related]
8. Structure-based design of small peptide inhibitors of protein kinase CK2 subunit interaction.
Laudet B; Barette C; Dulery V; Renaudet O; Dumy P; Metz A; Prudent R; Deshiere A; Dideberg O; Filhol O; Cochet C
Biochem J; 2007 Dec; 408(3):363-73. PubMed ID: 17714077
[TBL] [Abstract][Full Text] [Related]
9. Cloning, expression and properties of the alpha' subunit of casein kinase 2 from zebrafish (Danio rerio).
Antonelli M; Daniotti JL; Rojo D; Allende CC; Allende JE
Eur J Biochem; 1996 Oct; 241(1):272-9. PubMed ID: 8898916
[TBL] [Abstract][Full Text] [Related]
10. Identification of a novel potent, selective and cell permeable inhibitor of protein kinase CK2 from the NIH/NCI Diversity Set Library.
Guerra B; Hochscherf J; Jensen NB; Issinger OG
Mol Cell Biochem; 2015 Aug; 406(1-2):151-61. PubMed ID: 25963666
[TBL] [Abstract][Full Text] [Related]
11. Exploiting the repertoire of CK2 inhibitors to target DYRK and PIM kinases.
Cozza G; Sarno S; Ruzzene M; Girardi C; Orzeszko A; Kazimierczuk Z; Zagotto G; Bonaiuto E; Di Paolo ML; Pinna LA
Biochim Biophys Acta; 2013 Jul; 1834(7):1402-9. PubMed ID: 23360763
[TBL] [Abstract][Full Text] [Related]
12. Chemical proteomics and functional proteomics strategies for protein kinase inhibitor validation and protein kinase substrate identification: applications to protein kinase CK2.
Gyenis L; Turowec JP; Bretner M; Litchfield DW
Biochim Biophys Acta; 2013 Jul; 1834(7):1352-8. PubMed ID: 23416530
[TBL] [Abstract][Full Text] [Related]
13. Proteomics perturbations promoted by the protein kinase CK2 inhibitor quinalizarin.
Franchin C; Salvi M; Arrigoni G; Pinna LA
Biochim Biophys Acta; 2015 Oct; 1854(10 Pt B):1676-86. PubMed ID: 25882195
[TBL] [Abstract][Full Text] [Related]
14. Unbiased functional proteomics strategy for protein kinase inhibitor validation and identification of bona fide protein kinase substrates: application to identification of EEF1D as a substrate for CK2.
Gyenis L; Duncan JS; Turowec JP; Bretner M; Litchfield DW
J Proteome Res; 2011 Nov; 10(11):4887-901. PubMed ID: 21936567
[TBL] [Abstract][Full Text] [Related]
15. Discovery of holoenzyme-disrupting chemicals as substrate-selective CK2 inhibitors.
Kufareva I; Bestgen B; Brear P; Prudent R; Laudet B; Moucadel V; Ettaoussi M; Sautel CF; Krimm I; Engel M; Filhol O; Borgne ML; Lomberget T; Cochet C; Abagyan R
Sci Rep; 2019 Nov; 9(1):15893. PubMed ID: 31685885
[TBL] [Abstract][Full Text] [Related]
16. CIGB-300: A peptide-based drug that impairs the Protein Kinase CK2-mediated phosphorylation.
Perea SE; Baladrón I; Valenzuela C; Perera Y
Semin Oncol; 2018 Jan; 45(1-2):58-67. PubMed ID: 30318085
[TBL] [Abstract][Full Text] [Related]
17. CIGB-300, a novel proapoptotic peptide that impairs the CK2 phosphorylation and exhibits anticancer properties both in vitro and in vivo.
Perea SE; Reyes O; Baladron I; Perera Y; Farina H; Gil J; Rodriguez A; Bacardi D; Marcelo JL; Cosme K; Cruz M; Valenzuela C; López-Saura PA; Puchades Y; Serrano JM; Mendoza O; Castellanos L; Sanchez A; Betancourt L; Besada V; Silva R; López E; Falcón V; Hernández I; Solares M; Santana A; Díaz A; Ramos T; López C; Ariosa J; González LJ; Garay H; Gómez D; Gómez R; Alonso DF; Sigman H; Herrera L; Acevedo B
Mol Cell Biochem; 2008 Sep; 316(1-2):163-7. PubMed ID: 18575815
[TBL] [Abstract][Full Text] [Related]
18. Molecular Pathways: Emergence of Protein Kinase CK2 (CSNK2) as a Potential Target to Inhibit Survival and DNA Damage Response and Repair Pathways in Cancer Cells.
Rabalski AJ; Gyenis L; Litchfield DW
Clin Cancer Res; 2016 Jun; 22(12):2840-7. PubMed ID: 27306791
[TBL] [Abstract][Full Text] [Related]
19. The effect of polylysine on casein-kinase-2 activity is influenced by both the structure of the protein/peptide substrates and the subunit composition of the enzyme.
Meggio F; Boldyreff B; Marin O; Marchiori F; Perich JW; Issinger OG; Pinna LA
Eur J Biochem; 1992 May; 205(3):939-45. PubMed ID: 1577011
[TBL] [Abstract][Full Text] [Related]
20. Dual effect of lysine-rich polypeptides on the activity of protein kinase CK2.
Romero-Oliva F; Jacob G; Allende JE
J Cell Biochem; 2003 May; 89(2):348-55. PubMed ID: 12704797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
